Rein Therapeutics holds annual shareholder meeting - RNTX News | RalliesRein Therapeutics holds annual shareholder meeting
R
RNTX• Annual shareholder meeting results
- Rein Therapeutics held its 2026 annual shareholder meeting on July 20, 2026.
- Shareholders backed a charter amendment raising authorized common shares to 200 million from 100 million; the filing does not confirm implementation.
- Shareholders ratified CBIZ CPAs as independent auditor for the year ending Dec. 31, 2026.
- Two Class III directors were selected to serve through the 2029 annual meeting.
•
